Angiogenesis, vascular endothelial growth factor and the endometrium

被引:186
作者
Smith, SK [1 ]
机构
[1] Univ Cambridge, Rosie Matern Hosp, Dept Obstet & Gynaecol, Cambridge CB2 2SW, England
关键词
angiogenesis; endometrium; human; menorrhagia; vascular endothelial growth factor;
D O I
10.1093/humupd/4.5.509
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Angiogenesis is an essential component of endometrial renewal. The formation of new vessels depends on Interactions between various hormones and growth factors, and this review focuses on the expression of angiogenic growth factors in the human endometrium, Peptide and non-peptide angiogenic factors interact during endometrial renewal, including epidermal growth factor (EGF), transforming growth factors (e.g. TGF-beta), platelet-derived endothelial growth factor/ thymidine phosphorylase (PD-ECGF/TP), tumour necrosis growth factors and vascular endothelial growth factor (VEGF). Their role in the proliferation and migration of endothelial cells from pre-existing vessels is described, concentrating on VGEF and its receptors (VEG-R1 and -R2), and the fibroblast growth factor (FGF) family. The actions of the products of the VEGF gene are outlined, and the hormonal and non-hormonal control of their localization in the human endometrium and biological actions on vasculature and coagulation are described, Finally, the role of VEGF in menorrhagia is assessed.
引用
收藏
页码:509 / 519
页数:11
相关论文
共 130 条
[1]   Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4) [J].
Achen, MG ;
Jeltsch, M ;
Kukk, E ;
Mäkinen, T ;
Vitali, A ;
Wilks, AF ;
Alitalo, K ;
Stacker, SA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (02) :548-553
[2]   Thrombospondin-1 [J].
Adams, JC .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 1997, 29 (06) :861-865
[3]   Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology [J].
Banks, RE ;
Forbes, MA ;
Kinsey, SE ;
Stanley, A ;
Ingham, E ;
Walters, C ;
Selby, PJ .
BRITISH JOURNAL OF CANCER, 1998, 77 (06) :956-964
[4]  
Barleon B, 1997, J BIOL CHEM, V272, P10382
[5]   THE FGF FAMILY OF GROWTH-FACTORS AND ONCOGENES [J].
BASILICO, C ;
MOSCATELLI, D .
ADVANCES IN CANCER RESEARCH, 1992, 59 :115-165
[6]  
Bonnar J, 1996, BRIT MED J, V313, P579
[7]   INDIRECT ANGIOGENIC CYTOKINES UP-REGULATE VEGF AND BFGF GENE-EXPRESSION IN VASCULAR SMOOTH-MUSCLE CELLS, WHEREAS HYPOXIA UP-REGULATES VEGF EXPRESSION ONLY [J].
BROGI, E ;
WU, TG ;
NAMIKI, A ;
ISNER, JM .
CIRCULATION, 1994, 90 (02) :649-652
[8]   REQUIREMENT OF VASCULAR INTEGRIN ALPHA(V)BETA(3) FOR ANGIOGENESIS [J].
BROOKS, PC ;
CLARK, RAF ;
CHERESH, DA .
SCIENCE, 1994, 264 (5158) :569-571
[9]   TRANSFORMING GROWTH-FACTOR-BETA MEDIATES THE PROGESTERONE SUPPRESSION OF AN EPITHELIAL METALLOPROTEINASE BY ADJACENT STROMA IN THE HUMAN ENDOMETRIUM [J].
BRUNER, KL ;
RODGERS, WH ;
GOLD, LI ;
KORC, M ;
HARGROVE, JT ;
MATRISIAN, LM ;
OSTEEN, KG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (16) :7362-7366
[10]   Oxygen sensing and molecular adaptation to hypoxia [J].
Bunn, HF ;
Poyton, RO .
PHYSIOLOGICAL REVIEWS, 1996, 76 (03) :839-885